Tadalafil for erectile dysfunction: excellent safety and tolerance.
- Author:
Wen-Jun BAI
1
Author Information
1. Research Institute for Male Health, Peking University People's Hospital, Beijing 100044, China. bai-wj@163.com
- Publication Type:Journal Article
- MeSH:
Carbolines;
adverse effects;
therapeutic use;
Drug Tolerance;
Erectile Dysfunction;
drug therapy;
Humans;
Male;
Phosphodiesterase Inhibitors;
adverse effects;
therapeutic use;
Tadalafil
- From:
National Journal of Andrology
2009;15(1):92-95
- CountryChina
- Language:Chinese
-
Abstract:
As a novel phosphodiesterase type 5 (PDE5) inhibitor, tadalafil is administered orally for the treatment of erectile dysfunction (ED). In addition to its outstanding efficacy that lasts 36 hours, tadalafil shows an excellent safety and tolerance, with only a few transient mild to moderate adverse events. Usually ED patients are concomitantly afflicted with multiple pre-existing medical conditions or receive a range of drugs at the same time. Therefore, it is essential to understand its safety in general population and some special high-risk cohorts.
